An adaptive clinical Type 1 diabetes control protocol to optimize conventional self‐monitoring blood glucose and multiple daily‐injection therapy
From MaRDI portal
Publication:3497724
Recommendations
- Management of diabetes using adaptive control
- Risk Analysis of Blood Glucose Data: A Quantitative Approach to Optimizing the Control of Insulin Dependent Diabetes
- Model-based control of plasma glycemia: tests on populations of virtual patients
- A fast generalizable solution method for glucose control algorithms
- New principles and adequate robust control methods for artificial pancreas
Cited in
(6)- Robust \(\mu\)-synthesis: towards a unified glucose control in adults, adolescents and children with T1DM
- Suboptimal H ∞ hyperglycemia control on T1DM accounting biosignals of exercise and nocturnal hypoglycemia
- Management of diabetes using adaptive control
- Risk Analysis of Blood Glucose Data: A Quantitative Approach to Optimizing the Control of Insulin Dependent Diabetes
- Estimation of secondary effect parameters in glycaemic dynamics using accumulating data from a virtual type 1 diabetic patient
- Diabetes payer-addressable burden: an actuarial analysis
This page was built for publication: An adaptive clinical Type 1 diabetes control protocol to optimize conventional self‐monitoring blood glucose and multiple daily‐injection therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3497724)